About PlusGen India
PlusGen India is a Healthcare company based in Gurugram (India) founded in 2022. Distributes pharmaceuticals including antibiotics and cardiovascular drugs to retailers and institutions. It operates on a B2B model. The company has 1 employees. Its Indian entity Plusgen India Private Limited reported revenue of ₹2.49 Cr. PlusGen India offers products and services including Antibiotics, Anti-Diabetic Medications, Cardiovascular Drugs, Anti-Cancer Therapies, and Analgesics and NSAIDs. Its focus areas include Pharmaceuticals, Drug Distribution, Therapeutic Areas and Medical Products. Its competitors include Entero Healthcare and Keimed; 2 of its 2 listed competitors have raised funding.
Company details
PlusGen India Private Limited, founded in 2023, operates as a pharmaceutical distributor in India, serving as the sole selling agent for Gufic Biosciences affordable medicines. The company manages a portfolio of over 800 products, starting with 300 SKUs, and focuses on therapeutic areas like antibiotics and anti-diabetic medications. It employs a network of partners for nationwide distribution, targeting retailers, pharmacies, nursing homes, and hospitals, with a strategy emphasizing retail and institutional channels. Based in Delhi, it ensures quality and accessibility in healthcare.
- Headquarters Gurugram, India
- Employees 1
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website plusgenindia.com
- Social Instagram
- Legal Name Plusgen India Private Limited
- Date of Incorporation 26 Oct, 2022
- Jurisdiction Gurugram, Haryana, India
- Annual Revenue₹2.49 Cr
FY 2024
- Net Profit₹4.3 Lakh
FY 2024 · 2% margin
- EBITDA₹5.9 Lakh
FY 2024 · 2% margin
- Employee Count1
Associated legal entities of PlusGen India
PlusGen India operates through Plusgen India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Plusgen India Private Limited CIN U74999HR2022PTC107380 | Active | 26 Oct 2022 | Gurugram, Haryana | ₹2.5 Cr | 2 | View details |
Products & Services of PlusGen India
PlusGen India offers a comprehensive portfolio of products and services, including Antibiotics, Anti-Diabetic Medications, Cardiovascular Drugs, Anti-Cancer Therapies, and Analgesics and NSAIDs.
Medications that combat bacterial infections for rapid recovery.
Help manage blood sugar levels and reduce long-term complications.
Treat hypertension and heart disease to optimize cardiac function.
Advanced therapies aimed at improving cancer patient survival rates.
Provide relief from pain and inflammation in various conditions.
Topical treatments for skin irritations and wound healing.
Board of directors of Plusgen India Private Limited (PlusGen India)
Plusgen India Private Limited is the primary company behind PlusGen India. The board of Plusgen India Private Limited currently have 2 directors; the longest-serving is Ashwani Kumar Bhatia, appointed in 2022.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ashwani Kumar Bhatia DIN 05270102 | Director | 26 Oct 2022 | 4 yrs | Plusgen India Private Limited |
| Anil Kumar DIN 02815214 | Director | 26 Oct 2022 | 4 yrs | Plusgen India Private Limited |
Financials of PlusGen India
Figures of Plusgen India Private Limited, the primary company behind PlusGen India, for FY 2024. Revenue was ₹2.49 Cr. Net profit was ₹4.3 Lakh (2% margin). EBITDA was ₹5.9 Lakh (2% margin).
- ₹2.49 CrRevenue · FY 2024
- ₹4.3 LakhNet profit · 2% margin
- ₹5.9 LakhEBITDA · 2% margin
- ₹15 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Plusgen India Private Limited are on its company page.
Detailed financial statements for PlusGen India
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of PlusGen India
PlusGen India has 2 listed competitors in our database, 2 of them funded. They include Entero Healthcare and Keimed.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. |
Detailed competitors of PlusGen India
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PlusGen India
PlusGen India was founded in 2022.
PlusGen India is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.
PlusGen India has 1 employees.
The primary company behind PlusGen India, Plusgen India Private Limited, reported revenue of ₹2.49 Cr for FY 2024.
PlusGen India Private Limited, founded in 2023, operates as a pharmaceutical distributor in India, serving as the sole selling agent for Gufic Biosciences affordable medicines. The company manages a portfolio of over 800 products, starting with 300 SKUs, and focuses on therapeutic areas like antibiotics and anti-diabetic medications. It employs a network of partners for nationwide distribution, targeting retailers, pharmacies, nursing homes, and hospitals, with a strategy emphasizing retail and institutional channels. Based in Delhi, it ensures quality and accessibility in healthcare.
PlusGen India's top competitors include Entero Healthcare and Keimed.
PlusGen India offers Antibiotics, Anti-Diabetic Medications, Cardiovascular Drugs, Anti-Cancer Therapies, and 2 more products and services.
PlusGen India operates through Plusgen India Private Limited.
The legal entities of PlusGen India currently have 2 directors, including Ashwani Kumar Bhatia, Anil Kumar.